Stockscreener 앱 받기
562.05
1.43%
-8.16
전일 마감가:
$570.21
열려 있는:
$563.23
하루 거래량:
151.57K
Relative Volume:
0.29
시가총액:
$44.28B
수익:
$4.45B
순이익/손실:
$1.10B
주가수익비율:
41.35
EPS:
13.591
순현금흐름:
$1.06B
1주 성능:
+0.74%
1개월 성능:
+8.24%
6개월 성능:
-2.24%
1년 성능:
-13.18%
1일 변동 폭
$559.03
$567.54
1주일 범위
$547.48
$571.75
52주 변동 폭
$500.61
$769.98
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, NTRA, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
562.05 | 44.28B | 4.45B | 1.10B | 1.06B | 13.59 |
TMO
Thermo Fisher Scientific Inc
|
693.25 | 256.33B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.27 | 163.28B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
407.80 | 58.78B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
177.75 | 50.11B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
462.97 | 45.49B | 3.77B | 449.25M | 240.68M | 7.8556 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-16 | 개시 | Goldman | Buy |
| 2026-10-12 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2026-04-15 | 개시 | Citigroup | Neutral |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-10-31 | 업그레이드 | Stifel | Hold → Buy |
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-08-05 | 재확인 | BTIG Research | Buy |
| 2025-07-01 | 개시 | Jefferies | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
DexCom Gears Up to Report Q3 Results: How to Play the Stock? - Zacks Investment Research
Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures? - Zacks Investment Research
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo! Finance Canada
IDEXX Laboratories, Inc. Estimates – NASDAQ:IDXX - TradingView
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock? - Zacks Investment Research
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Yahoo Finance
IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth? - Yahoo Finance
IDEXX Laboratories (NASDAQ:IDXX) Share Price, Forecast & Analysis - Stocks Down Under
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance UK
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings - Zacks Investment Research
Europe Companion Animal Diagnostics Market Size and Forecast, 20212031 | AI-Enabled Testing and Preventive Pet Care Fuel 9.5% CAGR and a US$2.27 Billion Opportunity - GlobeNewswire Inc.
IDEXX Laboratories (IDXX) Rebounds On Jefferies Support, Is It Still 20% Undervalued? - Yahoo Finance
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report? - Zacks Investment Research
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research
Jefferies Adjusts Price Target on IDEXX Laboratories to $705 From $795 - marketscreener.com
Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade - Zacks Investment Research
IDEXX Laboratories, Inc. (IDXX) Stock Price & News - Syfe
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance UK
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775 - Moomoo
IDEXX Laboratories Inc (IDXX): GF Score of 96 Signals Strong Out - GuruFocus
J.P. Morgan Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $750 - Moomoo
JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775 - Yahoo Finance
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Australia
IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 96 Tells Investors - GuruFocus
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Laboratories stock sits 36.51 percent below USD 747.00 target - ad-hoc-news.de
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
IDEXX Laboratories’ Q3 2026 Earnings: What to Expect - Barchart.com
IDEXX Laboratories’ Q3 2026 Earnings: What to Expect - inkl
IDEXX Laboratories’ Q3 2026 Earnings: What to Expect - Yahoo Finance
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
KeyBanc Initiates IDEXX Laboratories at Sector Weight - marketscreener.com
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight - Investing.com
IDEXX Laboratories (IDXX) Stock Forecast and Price Target 2026 - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
What IDEXX Laboratories Investors Missed Before The Fall - Simply Wall Street
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Analysts keep Moderate Buy on IDEXX Laboratories stock - AD HOC NEWS
IDEXX Laboratories stock after-hours at EUR 469.60: plus 1.94 percent versus prior close - AD HOC NEWS
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
아이덱스 래버러토리스 주식 (IDXX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LAWRENCE D KINGSLEY | Director |
Sep 04 '26 |
Proposed Sale |
532.08 |
2,203 |
1,172,178 |
0 |
| Kingsley Lawrence D | Director |
Sep 04 '26 |
Sale |
532.08 |
2,203 |
1,172,178 |
9,568 |
| Emerson Andrew | EVP, CFO and Treasurer |
Aug 20 '26 |
Option Exercise |
178.26 |
265 |
47,239 |
4,507 |
| FENNELL GEORGE | Executive Vice President |
Jun 01 '26 |
Option Exercise |
0.00 |
639 |
0 |
10,717 |
| Margaret Anne Szostak | Director |
May 20 '26 |
Proposed Sale |
553.58 |
1,344 |
744,012 |
0 |
| Kingsley Lawrence D | Director |
May 07 '26 |
Option Exercise |
0.00 |
339 |
0 |
9,568 |
| Peacock Karen | Director |
May 07 '26 |
Option Exercise |
0.00 |
101 |
0 |
102 |
| HOOLEY JOSEPH L | Director |
May 07 '26 |
Option Exercise |
0.00 |
158 |
0 |
276 |
| Vandebroek Sophie V. | Director |
May 07 '26 |
Option Exercise |
0.00 |
257 |
0 |
905 |
| JUNIUS DANIEL M | Director |
May 07 '26 |
Option Exercise |
0.00 |
257 |
0 |
3,561 |
0.06%
자본화:
|
볼륨(24시간):